BeiGene Latest Chinese Biotech To Double Down On mRNA For Cancer

 
• By Dexter Jie Yan
  
cancer vaccine
The deal with InnoRNA marks the second one BeiGene has signed in the mRNA field. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip